Objective To study the clinical effectiveness and safety of nasal intermittent positive pressure ventilation (NIPPV) in the initial treatment of neonatal respiratory distress syndrome (NRDS) and the initial setting of NIPPV parameters. Methods One hundred neonates with NRDS were divided into NIPPV group (n=50) and nasal continuous positive airway pressure (NCPAP) group (n=50). A randomized controlled study was conducted to compare the effectiveness of NIPPV versus NCPAP in the initial treatment of NRDS from the following aspects: reducing CO2 retention, improving oxygenation, reducing second endotracheal intubation and second use of pulmonary surfactant (PS), reducing the duration of invasive respiratory support, reducing the duration of oxygen use, and reducing the incidence of air leak, abdominal distension and ventilator-associated pneumonia. Results After 1 and 6 hours of noninvasive respiratory support, the NIPPV group was superior to the NCPAP group with respect to the reduction in CO2 retention and improvement in oxygenation (P<0.05); in addition, compared with the NCPAP group, the NIPPV group had significantly lower rates of second endotracheal intubation and second PS use, significantly shorter duration of invasive respiratory support and time of FiO2 >0.21, and significantly lower incidence of apnea and ventilator-associated pneumonia (P<0.05); there were no significant differences in the incidence of air leak and abdominal distention between the two groups. Conclusions NIPPV is effective and safe in the initial treatment of NRDS and holds promise for clinical application.
Key words
Neonatal respiratory distress syndrome /
Nasal intermittent positive pressure ventilation /
Nasal continuous positive airway pressure /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 孙秀静, 王丹华. 新生儿呼吸窘迫综合症的管理—欧洲共识指南2010版[J].中国新生儿杂志, 2010, 25(6): 378-380.
[2] Bancalari E, Claure N. Non-invasive ventilation of the preterm infant [J]. Early Hum Dev, 2008, 84(12): 815-819.
[3] Lampland AL, Meyers PA, Worwa CT, et al. Gas exchange and lung inflammation using nasal intermittent positive-pressure ventilation versus synchronized intermittent mandatory ventilation in piglets with saline lavage-induced lung injury: an observational study[J]. Crit Care Med, 2008, 36(1): 183-187.
[4] Davis PG, Morley CJ, Owen LS. Noninvasive respiratory support of preterm neonates with respiratory distress:continuous positive airway pressure and nasal intermittent positive pressure ventilation[J]. Semin Fetal Neonatal Med, 2009, 14(1): 14-20.
[5] 金汉珍,黄德珉,官希吉.实用新生儿学[M].第3版.北京:人民卫生出版社, 2003: 421-427.
[6] Sandri F, Ancora G, LanzoniA, et al. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial[J]. Arch Dis Child Fetal Neonatal Ed, 2004, 89(5): F394-F398.
[7] Ramanathan R. Nasal respiratory support through the nares: its time has come[J]. Perinatol, 2010, 30 Suppl: S67-S72.
[8] Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome[J]. Acta Paediatr, 2009, 98(9): 1412-1415.
[9] Sankaran K, Adegbite M. Noninvasive respiratory support in neonates: a brief review[J].中国当代儿科杂志, 2012, 14(9): 644-652.
[10] 高薇薇, 谭三智, 陈运彬, 等. 鼻塞式同步间歇指令通气和持续气道正压通气在早产儿呼吸窘迫综合征中的应用比较[J].中国当代儿科杂志, 2010, 12(7): 524-526.
[11] 唐仕芳, 赵锦宁, 沈洁, 等. 经鼻间歇和持续气道正压通气治疗新生儿呼吸窘迫综合征的Meta分析[J].中国循证儿科杂志, 2011, 6(4): 255-263.
[12] Owen LS, Morley CJ, Davis PG. Neonatal nasal intermittent positive pressure ventilation:what do we know in 2007?[J]. Arch Dis Child Fetal Neonatal Ed, 2007, 92(5): 414-418.
[13] Owen LS, Morley CJ, Davis PG. Pressure variation during ventilator generated nasal intermittent positive pressure ventilation in preterm infants[J]. Arch Dis Child Fetal. Neonatal.Ed, 2010, 95(5): F359-F364.